148 related articles for article (PubMed ID: 2804381)
1. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
Anderson DW; Epstein JS; Lee TH; Lairmore MD; Saxinger C; Kalyanaraman VS; Slamon D; Parks W; Poiesz BJ; Pierik LT
Blood; 1989 Nov; 74(7):2585-91. PubMed ID: 2804381
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-1).
Fang CT; Williams AE; Sandler SG; Slamon DJ; Poiesz BJ
Transfusion; 1988; 28(2):179-83. PubMed ID: 2832983
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays.
Hartley TM; Khabbaz RF; Cannon RO; Kaplan JE; Lairmore MD
J Clin Microbiol; 1990 Apr; 28(4):646-50. PubMed ID: 2185257
[TBL] [Abstract][Full Text] [Related]
4. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
Roberts BD; Foung SK; Lipka JJ; Kaplan JE; Hadlock KG; Reyes GR; Chan L; Heneine W; Khabbaz RF
J Clin Microbiol; 1993 Feb; 31(2):260-4. PubMed ID: 8432811
[TBL] [Abstract][Full Text] [Related]
6. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
7. Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Retrovirus Study Group of the French Society of Blood Transfusion.
Defer C; Coste J; Descamps F; Voisin S; Lemaire JM; Maniez M; Couroucé AM
Transfusion; 1995 Jul; 35(7):596-600. PubMed ID: 7631394
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
[TBL] [Abstract][Full Text] [Related]
9. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
Manns A; Murphy EL; Wilks R; Haynes G; Figueroa JP; Hanchard B; Barnett M; Drummond J; Waters D; Cerney M
Blood; 1991 Feb; 77(4):896-905. PubMed ID: 1993227
[TBL] [Abstract][Full Text] [Related]
10. Confirmatory tests for human T-cell leukemia virus type 1 (HTLV-1): western blot compared with RIPA on African sera.
Verdier M; Leonard G; Sangare A; Prince-David M; Bonis J; Barin F; Denis F
J Virol Methods; 1990 Dec; 30(3):283-9. PubMed ID: 2086599
[TBL] [Abstract][Full Text] [Related]
11. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
12. Examination of HTLV-I ELISA-positive leukemia/lymphoma patients by western blotting gave mostly negative or indeterminate reaction.
Srivastava BI; Gonzales C; Loftus R; Fitzpatrick JE; Saxinger CW
AIDS Res Hum Retroviruses; 1990 May; 6(5):617-27. PubMed ID: 2113820
[TBL] [Abstract][Full Text] [Related]
13. Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group.
Donegan E; Pell P; Lee H; Shaw GM; Mosley JW
Transfusion; 1992 Jan; 32(1):68-71. PubMed ID: 1731439
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II.
Gallo D; Diggs JL; Hanson CV
J Clin Microbiol; 1990 Sep; 28(9):2045-50. PubMed ID: 1977764
[TBL] [Abstract][Full Text] [Related]
16. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.
Chen YM; Lee TH; Samuel KP; Okayama A; Tachibana N; Miyoshi I; Papas TS; Essex M
J Virol; 1989 Nov; 63(11):4952-7. PubMed ID: 2677406
[TBL] [Abstract][Full Text] [Related]
17. Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-I/II serology.
Re MC; Furlini G; Ramazzotti E; Vignoli M; Zauli G; Lolli S; Monari P; Belletti D; Nanetti A; La Placa M
Microbiologica; 1992 Oct; 15(4):329-36. PubMed ID: 1331713
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
Aboulafia DM; Bennett C; Koga H; Keith D; Slamon D
Viral Immunol; 1992; 5(2):105-11. PubMed ID: 1616582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
